Oncology Institute (TOI) Change in Accured Expenses (2020 - 2026)

Oncology Institute has reported Change in Accured Expenses for 7 years, with the latest figure at $3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 52.63% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $903000.0 (down 86.46% YoY), and the FY2025 full-year result was -$448000.0, down 104.73% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $3.9 million, up from -$2.8 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $5.4 million in Q1 2024, with the low at -$3.4 million in Q2 2024.
• Historically, Change in Accured Expenses has averaged $1.1 million across 5 years, with a median of $526000.0 in 2022.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses plunged 332.23% — and 2024, when it surged 766.83%.
• Oncology Institute's Change in Accured Expenses stood at -$545000.0 in 2022, then soared by 609.72% to $2.8 million in 2023, then soared by 67.6% to $4.7 million in 2024, then sank by 160.93% to -$2.8 million in 2025, then soared by 238.1% to $3.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $3.9 million (Q1 2026), -$2.8 million (Q4 2025), and $127000.0 (Q3 2025), per Business Quant data.